Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The global landscape of lean metabolic dysfunction-associated steatotic liver disease: insight from Asia and the West. | Front Gastroenterol (Lausanne) | 2025 | 41822266 | PubTator, text mining | PubMed |
| Admixture mapping identifies complex trait associations with local ancestry in the All of Us Research Program. | medRxiv | 2025 | 41607652 | PubTator, text mining | PubMed |
| Association of the Rs738409 Polymorphism in PNPLA3 with Development and Severity of Nonalcoholic Fatty Liver Disease. | Indian J Endocrinol Metab | 2025 | 41497303 | PubTator, text mining | PubMed |
| Consuming your colors: carotenoid and retinol availability affects expression of color related genes in the mimic poison frog (Ranitomeya imitator). | BMC Genomics | 2025 | 41388497 | PubTator, text mining | PubMed |
| Genetic risk of alcohol-related liver cirrhosis: Associations of PNPLA3, TM6SF2, and a two-variant polygenic risk score. | Biomol Biomed | 2025 | 41384813 | PubTator, text mining | PubMed |
| Unraveling the Role of BAG3 in Hepatic Fibrosis: Genetic and Biomarker Insights in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | Int J Mol Sci | 2025 | 41373448 | PubTator, text mining | PubMed |
| Genetic predeterminants and recent advancements in steatotic liver disease: A roadmap toward precision hepatology. | World J Hepatol | 2025 | 41368108 | PubTator, text mining | PubMed |
| The impact of asparaginase phenotype-related single nucleotide polymorphisms on prognosis in pediatric B-cell precursor acute lymphoblastic leukemia. | Eur J Med Res | 2025 | 41351026 | PubTator, text mining | PubMed |
| Investigation of the impact of gynoid fat on steatotic and advanced liver diseases-Genomic and clinical perspectives from a large-scale population cohort. | Clin Nutr | 2025 | 41314110 | PubTator, text mining | PubMed |
| Genomic Signatures of MASLD: How Genomics Is Redefining Our Understanding of Metabolic Liver Disease. | Int J Mol Sci | 2025 | 41303369 | PubTator, text mining | PubMed |
| Extended Roles in Healthcare Delivery: What Is the Role of the Laboratory in Addressing Ethnicity-Related Healthcare Disparities? | Diagnostics (Basel) | 2025 | 41300943 | PubTator, text mining | PubMed |
| Mediterranean and low-fat diets are equally effective in MASLD resolution at 12 weeks regardless of PNPLA3 genotype: A randomized controlled trial. | Hepatol Commun | 2025 | 41284948 | PubTator, text mining | PubMed |
| Tissue-specific regulation of PNPLA3 promotes lipid remodeling in response to dietary and temperature stress. | bioRxiv | 2025 | 41278711 | PubTator, text mining | PubMed |
| [The role of the PNPLA3 gene rs738409 variant in the spectrum of metabolic dysfunction associated steatotic liver diseases]. | Orv Hetil | 2025 | 41275473 | PubTator, text mining | PubMed |
| PNPLA3-Ile148Met and TM6SF2-Glu167Lys increase susceptibility to metabolic dysfunction-associated steatotic liver disease in children. | Front Endocrinol (Lausanne) | 2025 | 41244049 | PubTator, text mining | PubMed |
| The emerging phenotype of nonalcoholic fatty liver disease in lean individuals: what's different? | Front Endocrinol (Lausanne) | 2025 | 41189623 | PubTator, text mining | PubMed |
| Helicobacter pylori infection as a risk factor in the development of metabolic dysfunction-associated steatotic liver disease. | World J Hepatol | 2025 | 41179711 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease in a Patient with Phelan-McDermid Syndrome. | Life (Basel) | 2025 | 41157259 | PubTator, text mining | PubMed |
| Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLD. | JHEP Rep | 2025 | 41143242 | PubTator, text mining | PubMed |
| PNPLA3-I148M genetic variant rewires lipid metabolism to drive programmed cell death in human hepatocytes. | JCI Insight | 2025 | 41118258 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=10